Teligent Price to Book Ratio 2012-2021 | TLGT
Historical price to book ratio values for Teligent (TLGT) over the last 10 years. The current price to book ratio for Teligent as of May 11, 2026 is 0.00.
| Teligent Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2021-12-17 | 0.03 | 0.00 | |
| 2021-06-30 | 0.53 | $-0.47 | -1.14 |
| 2021-03-31 | 0.62 | $-0.36 | -1.72 |
| 2020-12-31 | 0.75 | $-5.06 | -0.15 |
| 2020-09-30 | 0.72 | $-6.27 | -0.11 |
| 2020-06-30 | 2.42 | $-7.01 | -0.35 |
| 2020-03-31 | 2.80 | $-5.91 | -0.47 |
| 2019-12-31 | 4.26 | $-0.99 | -4.32 |
| 2019-09-30 | 9.50 | $-0.03 | -329.79 |
| 2019-06-30 | 6.30 | $1.24 | 5.06 |
| 2019-03-31 | 11.60 | $1.90 | 6.11 |
| 2018-12-31 | 13.70 | $3.43 | 4.00 |
| 2018-09-30 | 39.50 | $6.64 | 5.95 |
| 2018-06-30 | 34.60 | $7.23 | 4.78 |
| 2018-03-31 | 33.60 | $7.53 | 4.46 |
| 2017-12-31 | 36.30 | $8.38 | 4.33 |
| 2017-09-30 | 67.10 | $9.46 | 7.09 |
| 2017-06-30 | 91.50 | $10.94 | 8.36 |
| 2017-03-31 | 78.10 | $10.95 | 7.13 |
| 2016-12-31 | 66.10 | $10.66 | 6.20 |
| 2016-09-30 | 76.00 | $11.62 | 6.54 |
| 2016-06-30 | 71.40 | $12.01 | 5.94 |
| 2016-03-31 | 49.00 | $12.54 | 3.91 |
| 2015-12-31 | 89.00 | $12.60 | 7.07 |
| 2015-09-30 | 65.40 | $13.72 | 4.77 |
| 2015-06-30 | 63.00 | $14.11 | 4.46 |
| 2015-03-31 | 81.60 | $8.78 | 9.29 |
| 2014-12-31 | 88.00 | $7.41 | 11.88 |
| 2014-09-30 | 93.20 | $6.26 | 14.90 |
| 2014-06-30 | 53.10 | $1.69 | 31.35 |
| 2014-03-31 | 56.50 | $1.69 | 33.45 |
| 2013-12-31 | 30.50 | $1.54 | 19.83 |
| 2013-09-30 | 18.20 | $1.41 | 12.93 |
| 2013-06-30 | 14.30 | $1.43 | 9.99 |
| 2013-03-31 | 17.10 | $1.49 | 11.49 |
| 2012-12-31 | 10.40 | $1.51 | 6.91 |
| 2012-09-30 | 12.40 | $1.27 | 9.76 |
| 2012-06-30 | 10.30 | $1.60 | 6.45 |
| 2012-03-31 | 10.90 | $1.72 | 6.35 |
| 2011-12-31 | 11.50 | $1.87 | 6.14 |
| 2011-09-30 | 11.00 | $1.98 | 5.55 |
| 2011-06-30 | 11.10 | $2.08 | 5.34 |
| 2011-03-31 | 15.30 | $2.28 | 6.72 |
| 2010-12-31 | 16.80 | $2.51 | 6.70 |
| 2010-09-30 | 15.10 | $1.32 | 11.48 |
| 2010-06-30 | 10.10 | $2.79 | 3.62 |
| 2010-03-31 | 7.10 | $3.25 | 2.19 |
| 2009-12-31 | 7.80 | $2.76 | 2.83 |
| 2009-09-30 | 10.40 | $3.58 | 2.90 |
| 2009-06-30 | 11.50 | $4.26 | 2.70 |
| 2009-03-31 | 6.90 | $2.41 | 2.86 |
| 2008-12-31 | 4.80 | $1.98 | 2.42 |
| 2008-09-30 | 13.20 | $2.28 | 5.78 |
| 2008-06-30 | 23.50 | $2.27 | 10.35 |
| 2008-03-31 | 21.00 | $2.56 | 8.21 |
| 2007-12-31 | 14.10 | $2.79 | 5.05 |
| 2007-09-30 | 10.00 | $2.08 | 4.81 |
| 2007-06-30 | 7.50 | $2.10 | 3.56 |
| 2007-03-31 | 8.50 | $2.22 | 3.83 |
| 2006-12-31 | 11.60 | $1.68 | 6.93 |
| 2006-09-30 | 9.60 | $1.90 | 5.04 |
| 2006-06-30 | 13.00 | $2.17 | 5.98 |
| 2006-03-31 | 17.00 | $2.42 | 7.01 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.000B | $0.000B |
| Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $35.437B | 10.97 |
| BridgeBio Pharma (BBIO) | United States | $14.460B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.109B | 17.29 |
| Aspen Pharmacare (APNHY) | South Africa | $3.708B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.918B | 22.33 |
| Bausch Health Cos (BHC) | Canada | $2.086B | 1.50 |
| Taysha Gene Therapies (TSHA) | United States | $1.290B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $0.924B | 7.28 |
| Personalis (PSNL) | United States | $0.630B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.451B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.210B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.052B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |